Last $5.58 USD
Change Today +0.09 / 1.64%
Volume 23.3K
AMBI On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 4:00 PM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark Levis M.D., Ph.D.

Member of Hematology and Oncology Clinical Advisory Board, Ambit Biosciences Corporation
AgeTotal Calculated CompensationThis person is connected to 20 board members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background*

Mr. Mark Levis, M.D., Ph.D. has been Member of the Hematology and Oncology Clinical Advisory Board of Ambit Biosciences Corporation since February 28, 2008. Mr. Levis serves as Assistant Professor at Johns Hopkins University in Baltimore. Mr. Levis laboratory research focuses on the development of molecularly targeted therapies for leukemia. Currently, he is actively involved in the pre-clinical and clinical development of small molecule inhibitors of the receptor tyrosine ...

Read Full Background

Corporate Headquarters*

11080 Roselle Street
San Diego, California 92121

United States

Phone: 858-334-2100
Fax: 858-334-2192

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMBI:US $5.58 USD +0.09

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMBIT BIOSCIENCES CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.